Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quantum Biopharma (QNTM) Change in Account Payables (2019 - 2025)

Quantum Biopharma's Change in Account Payables history spans 7 years, with the latest figure at -$214343.0 for Q4 2025.

  • On a quarterly basis, Change in Account Payables fell 106.86% to -$214343.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.4 million, a 25.3% decrease, with the full-year FY2025 number at $4.2 million, down 2.07% from a year prior.
  • Change in Account Payables hit -$214343.0 in Q4 2025 for Quantum Biopharma, down from $4.1 million in the prior quarter.
  • Over the last five years, Change in Account Payables for QNTM hit a ceiling of $8.0 million in Q2 2021 and a floor of -$1.0 million in Q1 2024.
  • Historically, Change in Account Payables has averaged $3.5 million across 5 years, with a median of $3.3 million in 2024.
  • Biggest five-year swings in Change in Account Payables: soared 9062.83% in 2021 and later crashed 271.81% in 2024.
  • Tracing QNTM's Change in Account Payables over 5 years: stood at $676145.0 in 2021, then increased by 7.04% to $723769.0 in 2022, then decreased by 20.54% to $575080.0 in 2023, then soared by 443.46% to $3.1 million in 2024, then tumbled by 106.86% to -$214343.0 in 2025.
  • Business Quant data shows Change in Account Payables for QNTM at -$214343.0 in Q4 2025, $4.1 million in Q3 2025, and $3.2 million in Q2 2025.